About Regis Technologies
Regis Technologies is a company based in Morton Grove (United States) founded in 1956 was acquired by Esteve in July 2025. The company has 107 employees as of December 31, 2021. Regis Technologies offers products and services including Custom API Development, cGMP Manufacturing, Chromatography Columns, and Specialty Reagents. Regis Technologies operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others.
- Headquarter Morton Grove, United States
- Employees 107 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Regis Technologies Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$229.74 K (USD), Grant
Jul 01, 2021
-
Investors
First AmBank
& 2 more
-
Employee Count
107
as on Dec 31, 2021
-
Acquired by
Esteve
(Jul 31, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Regis Technologies
Regis Technologies offers a comprehensive portfolio of products and services, including Custom API Development, cGMP Manufacturing, Chromatography Columns, and Specialty Reagents.
Service for developing and manufacturing pharmaceutical APIs.
Compliance-focused manufacturing for clinical and commercial APIs.
Specialized columns for HPLC and SFC separations.
Reagents for ion pairing and derivatizing in analysis.
People of Regis Technologies
Unlock access to complete
Funding Insights of Regis Technologies
Investors in Regis Technologies
Regis Technologies has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include First AmBank, HHS and Esteve.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Commercial banking services are provided to businesses and individuals.
|
Locked | Locked | Locked | |
|
Therapies for chronic pain treatment are developed by Esteve.
|
Locked | Locked | Locked |
Investor details for Regis Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Regis Technologies
Investment portfolio details for Regis Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Regis Technologies
Detailed financials for Regis Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Regis Technologies Comparisons
Peer comparison for Regis Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Regis Technologies
Regis Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| Locked | Locked | Locked |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| Locked | Locked | Locked |
Provider of proprietary filtration solutions for life science
|
|
| Locked | Locked | Locked |
Small molecule analysis and purification services are provided using chromatography.
|
|
| Locked | Locked | Locked |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
Detailed competitors of Regis Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Regis Technologies
Complete news archive for Regis Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Regis Technologies
Regis Technologies was founded in 1956 and raised its 1st funding round 49 years after it was founded.
Regis Technologies is headquartered in Morton Grove, United States. It is registered at Morton Grove, Illinois, United States.
Louis Glunz IV is the current CEO of Regis Technologies.
As of Dec 31, 2021, the latest employee count at Regis Technologies is 107.
Regis Technologies offers synthesis, analytical and separation services to pharma companies to advance active pharmaceutical ingredient (API) and intermediates from initial process development and scale-up phases to final validation and commercial manufacturing. The company has special expertise in Supercritical Fluid Chromatography (SFC) and chiral compound development and separation. The companys service portfolio includes custom API and HPAPI manufacturing, analytical method development, cGMP non-GMP SFC separations, process research services (synthetic route modification and process validation) and quality control services. The company offers proprietary chromatography products with a special chiral emphasis.
Regis Technologies's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Regis Technologies offers Custom API Development, cGMP Manufacturing, Chromatography Columns, and Specialty Reagents.
Regis Technologies has 3 investors. Key investors include First AmBank, HHS, and Esteve.